Back to Browse Journals » Nature and Science of Sleep » Volume 4

Shift work: health, performance and safety problems, traditional countermeasures, and innovative management strategies to reduce circadian misalignment

Authors Smith MR, Eastman CI

Published Date September 2012 Volume 2012:4 Pages 111—132

DOI http://dx.doi.org/10.2147/NSS.S10372

Received 13 July 2012, Accepted 21 August 2012, Published 27 September 2012

Mark R Smith, Charmane I Eastman

Biological Rhythms Research Laboratory, Rush University Medical Center, Chicago, IL, USA

Abstract: There are three mechanisms that may contribute to the health, performance, and safety problems associated with night-shift work: (1) circadian misalignment between the internal circadian clock and activities such as work, sleep, and eating, (2) chronic, partial sleep deprivation, and (3) melatonin suppression by light at night. The typical countermeasures, such as caffeine, naps, and melatonin (for its sleep-promoting effect), along with education about sleep and circadian rhythms, are the components of most fatigue risk-management plans. We contend that these, while better than nothing, are not enough because they do not address the underlying cause of the problems, which is circadian misalignment. We explain how to reset (phase-shift) the circadian clock to partially align with the night-work, day-sleep schedule, and thus reduce circadian misalignment while preserving sleep and functioning on days off. This involves controlling light and dark using outdoor light exposure, sunglasses, sleep in the dark, and a little bright light during night work. We present a diagram of a sleep-and-light schedule to reduce circadian misalignment in permanent night work, or a rotation between evenings and nights, and give practical advice on how to implement this type of plan.

Keywords: circadian rhythms, night work, bright light, phase-shifting, sleep, melatonin

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Corrigendum]

Yu L, Wang XL, Zhu D, Ding WC, Wang LM, Zhang CL, Jiang XH, Shen H, Liao SJ, Ma D, Hu Z, Wang H

OncoTargets and Therapy 2015, 8:365-366

Published Date: 4 February 2015

Nanomedicine strategies for treatment of secondary spinal cord injury

White-Schenk D, Shi R, Leary JF

International Journal of Nanomedicine 2015, 10:923-938

Published Date: 29 January 2015

Optimal management of breast cancer in the elderly patient: current perspectives

Le Saux O, Ripamonti B, Bruyas A, Bonin O, Freyer G, Bonnefoy M, Falandry C

Clinical Interventions in Aging 2015, 10:157-174

Published Date: 6 January 2015

Photothermal cancer therapy using graphitic carbon–coated magnetic particles prepared by one-pot synthesis

Lee HJ, Sanetuntikul J, Choi ES, Lee BR, Kim JH, Kim E, Shanmugam S

International Journal of Nanomedicine 2015, 10:271-282

Published Date: 30 December 2014

Single-step transepithelial ASLA (SCHWIND) with mitomycin-C for the correction of high myopia: long term follow-up

Aslanides IM, Georgoudis PN, Selimis VD, Mukherjee AN

Clinical Ophthalmology 2015, 9:33-41

Published Date: 30 December 2014

Safety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapy

Jordão MLS, Hatanaka M, Ogundele A, Moraes Silva MR, Vessani RM

Clinical Ophthalmology 2014, 8:1527-1534

Published Date: 18 August 2014

Melanocytoma of the ciliary body misdiagnosed as iridodialysis

Kim M, Lee SJ

Clinical Ophthalmology 2014, 8:1051-1053

Published Date: 29 May 2014

Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma

Zhou X, Zhang M, Yung B, Li H, Zhou C, Lee LJ, Lee RJ

International Journal of Nanomedicine 2012, 7:5465-5474

Published Date: 16 October 2012

Management challenges arising from a traumatic 360 degree cyclodialysis cleft

Trikha S, Turnbull AMJ, Agrawal SS, Amerasinghe N, Kirwan JF

Clinical Ophthalmology 2012, 6:257-260

Published Date: 17 February 2012